Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with a basic error screen. This blocks access to the full study record and navigation.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page shows Revision: v3.6.6, updating the previous revision. This reflects a minor update to the page's build or deployment without modifying the study details.SummaryDifference0.1%

- Check44 days agoChange DetectedThe study record revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This represents a minor update to the record's metadata rather than any substantive changes to the study content.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor page update. No substantive study details or eligibility criteria appear to be affected.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision/version tag was updated from v3.6.2 to v3.6.3. This reflects a minor backend/template update and does not change the study information displayed.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page’s revision tag has been updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page content or formatting and does not modify the study data or outcomes.SummaryDifference0.1%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.